The HIV-1 epidemic is heterogeneous with various subtypes prevalent.Subtype-specific differences in disease progression rate have been reported; however the mechanisms underlying this heterogeneity are still unknown.We investigated whether there were subtype-specific replication capacity differences in recombinant viruses possessing patient-derived gag-protease genes from the Majengo sex worker cohort based in Nairobi, Kenya.
Antiretroviral therapy-naïve patients were recruited (n=103).Patient-derived gag-protease NL4-3 chimeric viruses were generated and their replication capacities assayed in an HIV-1-inducible green fluorescent protein reporter T cell line.Replication capacities of NL4-3 recombinant viruses bearing subtypes A, C, D and inter-subtype recombinants gag-protease were compared.An exploratory codon-by-codon analysis was performed using Kruskal-Wallis test to identify amino acid residues associated with differences in replication capacity for the subtype A recombinant viruses.
There were 57 (56%) subtype A, 16 (15.5%) C, 13 (12.6%) D and 17 (16%) inter-subtype recombinant viruses studied.There were no significant differences in CD4 T cell counts or viral loads according to subtypes (ANOVA; p=0.53 and p=0.91 respectively). There were significant differences in viral replication capacities between the different subtypes (p=0.0001, ANOVA), with subtypes A and C displaying lower replication capacity compared to subtype D (p=0.0006 and p=0.0004 respectively) and inter-subtype recombinants (p=0.0006 and p=0.0006 respectively).We identified six amino acids that were significantly (p<0.05 and q<0.2) associated with reduced replication capacity in subtype A (L75I, I107L, S125S, S126S, N315N and S499S).The polymorphism 107L and consensus amino acid 315N were significantly more frequent in subtype A (Chi square test; p=10-8 and p=0.01 respectively) and were associated with reduced replication capacity.
These data show a hierarchy of Gag-protease driven replicative fitness where subtypes A/C are less fit than D, which is also less fit than inter-subtype recombinants.The data is consistent with reported differences in subtype-specific differences in rate of disease progression.We identified amino acids that may contribute to these differences.Further studies to better understand the mechanisms underlying these differences are warranted.Furthermore, these data may have implications for the uneven spread and expansion of HIV-1 subtypes in the global epidermic.